Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Researchers Create Placenta-On-A-Chip To Study Biology Of Human Placenta

National Institutes of Health (NIH) researchers want to study the biology of human placenta to better understand its role in pregnancy.   But, studying the human placenta has challenges.  Because the placenta is a temporary organ that only develops during pregnancy, it comes with a shelf life, a wide range of variables and can pose a risk to the […]

Read More »

ACEP Issues Statement Following Supreme Court Verdict

WASHINGTON, June 26, 2015 /PRNewswire-USNewswire/ — The decision today by the Supreme Court will prevent millions of people from losing their health insurance, but does not stem the rising tide of visits to the nation’s emergency departments or solve other problems emerging in the post-Affordable Care Act health care system, according to a statement from […]

Read More »

Pro Bono Bio Launches Its North American Operations and Funds International Expansion

North American expansion and committed funding to drive medium term growth. LONDON, June 26, 2015 /PRNewswire/ – Pro Bono Bio, the world’s leading nanotechnology company offering health and lifestyle products, has launched its North American operations with headquarters based in Toronto, Canada and secured US$15M in funding to accelerate the global launches of FLEXISEQ™ and […]

Read More »

Viagra, Melanoma And The Problem With Big Data

This week saw the climax (or, for those who like to demonize the global pharmaceutical industry, perhaps the anti-climax) of a year-long saga linking an increased risk of melanoma with drugs such as sildenafil (better known as Viagra) used to treat erectile dysfunction. The story began in 2014 when a team of Boston scientists observed […]

Read More »

Celladon says may liquidate; suspends gene therapy development

Drug developer Celladon Corp said on Friday it may liquidate itself if it were unable to find a buyer, and was suspending development of its gene therapy for heart failure. The company’s shares fell 38 percent to $1.36 in premarket trading. Celladon said if it were to liquidate during the third quarter ending September, the […]

Read More »

Supreme Court Upholds Obama’s Health Subsidies

WASHINGTON—The Supreme Court on Thursday upheld a pillar of the Affordable Care Act, rescuing for the second time the most ambitious social program in nearly 50 years and ensuring that the law’s ultimate fate will be in the hands of the political proces The 6-3 ruling, written by Chief Justice John Roberts, upheld a signature […]

Read More »

Valeant Pharmaceuticals And Zoetis: A True Mega Deal Is On The Horizon

Call it conspicuous consumption. Serial acquirer Valeant Pharmaceuticals, an anointed stock in the portfolios of some of the largest hedge funds in Manhattan, appears to be on the prowl for a new takeover after closing its $11 billion acquisition of Salix Pharmaceuticals in mid-March. The Michael Pearson-led company has reportedly made an opening bid for Zoetis, a $25 […]

Read More »

It’s Time For The GOP To Embrace The Obamacare Exchanges

Here’s a wake-up call to conservatives: Unless you change something fast, your response to the Affordable Care Act will go down in history as a series of tactical errors that created a gigantic government mandate while simultaneously betraying your own principles. The Supreme Court’s resounding 6-3 rejection of King v. Burwell — a challenge to […]

Read More »

EYLEA (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion

TARRYTOWN, N.Y., June 26, 2015 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare’s Japanese subsidiary, Bayer Yakuhin, Ltd., received approval for EYLEA® (aflibercept) Injection by the Ministry of Health, Labour and Welfare (MHLW) in Japan for the treatment of patients with macular edema secondary to retinal vein occlusion (RVO). This new indication […]

Read More »

Less Soda Being Chosen With McDonald’s Happy Meals

Children have been drinking less soda and eating more fruit and yogurt at McDonald’s restaurants, the company and a partner said in their first report on the fast-food giant’s efforts to offer healthier options for its Happy Meals. The report was issued Thursday by McDonald’s Corp. and the Alliance for a Healthier Generation, a nonprofit […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom